Home > Journals > Italian Journal of Vascular and Endovascular Surgery > Past Issues > Italian Journal of Vascular and Endovascular Surgery 2013 September;20(3) > Italian Journal of Vascular and Endovascular Surgery 2013 September;20(3):151-5

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

ORIGINAL ARTICLES   

Italian Journal of Vascular and Endovascular Surgery 2013 September;20(3):151-5

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Preliminary results in endovascular treatment of abdominal aortic aneurysms by TriVascular Ovation endoprotesis. Report of the experience of two centers of vascular surgery

Nano G. 1, Mazzaccaro D. 1, Stegher S. 1, Occhiuto M. T. 1, Malacrida G. 1, Tealdi D. G. 1, Alberti A. 2, Volpe P. 2

1 First Unit of Vascular Surgery IRCCS Policlinico San Donato University of Milan, Milan, Italy; 2 Department of Vascular Surgery Riuniti Hospital of Reggio Calabria Reggio Calabria, Italy


PDF


Aim: We report our preliminary experience with the use of the TriVascular Ovation endograft system for the treatment of abdominal aortic aneurysms (AAA).
Methods: Data from patients treated for AAA using the Ovation endograft at two centers from January 2011 to September 2012 were retrospectively collected and reviewed. Main outcomes included primary success, survival, complications, and device-related events at 30-days.
Results: Thirty-seven patients (male: 95%, mean age: 76 yr) were treated for AAA (mean diameter: 54 mm) with the Ovation endograft, mainly using local or regional anesthesia (86.5% of cases). Percutaneous femoral access was utilized in 73% of cases. Primary success was achieved in 89.2% of cases, as 4 adjunctive procedures were required including two distal extensions (type 1b endoleak and iliac limb disconnection resulting in type III endoleak) and two bypass surgeries (limb graft occlusion and gate cannulation failure). No deaths, major complications, endoleaks, AAA enlargement, AAA rupture, stent fracture, migration, or endovascular or surgical reintervention were reported at 30-days.
Conclusion: Our initial experience with the Ovation endograft demonstrated encouraging 30-day results for the treatment of AAA.

top of page